UC cancer research presented at national meeting
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
October 24, 2022
University of Cincinnati researchers presented results from the first-in-human trial of FLASH radiotherapy at the ASTRO 2022 annual meeting, with data suggesting FLASH may hold promise as a potential treatment for tough-to-kill tumors.
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
June 14, 2022
The University of Cincinnati's Jordan Kharofa, MD, delivered a poster presentation at the American Society of Clinical Oncology annual meeting on new research on how diet and the microbiome affects young colorectal cancer patients.
April 3, 2023
University of Cincinnati researchers recently published findings in the journal Cancer that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
April 6, 2023
U.S. News and World Report highlighted research led by the University of Cincinnati's Jordan Kharofa that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
February 24, 2021
Climbing the ranks in the research field isn’t easy. Doing it with a physical disability is even more difficult. But Christina Wicker is doing just that at the University of Cincinnati.
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
January 27, 2021
University of Cincinnati researchers have tested a new combination therapy that showed reduced growth of head and neck cancer in an animal-based study.